精神健康状况成人中天然保健品不良反应研究(SONAR):横断面研究
该研究在加拿大阿尔伯塔省和安大略省11家精神健康门诊筛查了3079例成人患者,通过首次就诊问卷和医护人员报告收集处方药、天然保健品(NHP)使用及近30天不良事件(AE)。结果显示447例(14.9%)报告620例AE,多数AE见于同时使用NHP和处方药者(58.8%),联合使用增加AE风险(OR 2.1;p<0.001;95%CI 1.7-2.6)。
要点
- 同时使用NHP和处方药的精神健康患者AE报告率更高,OR为2.1。
- 多数AE(58.8%)发生于NHP与处方药联合使用者。
- 主动监测在精神健康门诊可行,有助于加强药物警戒。
核心结论
- 同时使用处方药和NHP的成人精神健康患者比单用处方药或单用NHP者更可能报告不良事件。
- 多重用药增加不良事件的可能性。
研究设计与样本
- 在加拿大阿尔伯塔省和安大略省11家精神健康门诊开展的主动监测横断面研究,筛查3079例成人患者。
- 首次就诊时填写问卷,询问处方药使用、NHP使用及过去一个月内经历的不良健康事件,医护人员也报告AE。
主要发现
- 447例患者(14.9%)共报告620例AE。
- AE分布:NHP与处方药联合使用组58.8%,单用处方药组37.1%,单用NHP组3.4%,两者均不用组0.67%。
- 联合使用NHP与处方药增加AE可能性(OR 2.1;p<0.001;95%CI 1.7-2.6)。
临床怎么用
- 临床应主动询问精神健康患者NHP与处方药的联合使用情况,并监测不良事件。
- 在精神健康门诊开展主动监测有助于发现NHP相关AE和药物相互作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Mental illness is a leading cause of non-fatal disease burden worldwide. Natural health products (NHPs) are sought by patients with mental health conditions as a safer and more 'natural' option than conventional pharmacotherapy; however, the possible adverse events (AE) and interactions between NHPs and prescription medicines are not fully known. OBJECTIVES: The aim of this study was to determine (i) the prevalence of adult patients with mental health conditions taking prescription medications only, NHPs only, NHPs and prescription medications concurrently, or neither, (ii) which prescription medications and NHPs are most commonly used, (iii) AEs (serious and non-serious) experienced in the last 30 days for each product use group. METHODS: Mental health clinics in Alberta and Ontario, Canada, were included in an active surveillance study investigating NHP-drug interactions. On their first clinic visit, adult mental health patients were provided with a form inquiring about prescription drug use, NHP use, and any undesirable health events experienced in the last month. Healthcare professionals were also asked to report AEs. RESULTS: A total of 3079 patients were screened at 11 mental health clinics in Alberta and Ontario. In total, 620 AEs were reported in 447 patients (14.9%). The majority of adverse events were seen in patients using both NHPs and prescription medicines (58.8%), followed by patients taking only prescription medicines (37.1%), NHPs only (3.4%) and neither (0.67%). Combining NHPs and prescription medications increases the likelihood of experiencing AEs (OR 2.1; p < 0.001; 95% CI 1.7-2.6). CONCLUSIONS: Adult patients with mental health conditions who are taking both prescription medications and NHPs are more likely to report an adverse event than patients taking prescription drugs or NHPs alone. Polypharmacy increases the likelihood of an adverse event. Active surveillance is feasible and could contribute to enhanced pharmacovigilance.
引用
- Zorzela L, Khamba B, Sparks E, et al. Study of Natural Products Adverse Reactions (SONAR) in Adults with Mental Health Conditions: A Cross-Sectional Study. Drug Saf. 2021. PMID: 34322863. doi:10.1007/s40264-021-01092-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。